Management of Buprenorphine Allergy
Immediate Management
- For severe reactions (anaphylaxis), the British Journal of Anaesthesia recommends following local advanced life support guidelines including IV epinephrine 1 mg for grade IV reactions, administering crystalloid fluid boluses as needed, and monitoring in a healthcare setting for at least 6 hours or until stable 1
Alternative Pain Management Options
- The American College of Physicians, as published in the Annals of Internal Medicine, suggests switching to a full opioid agonist with a different chemical structure (such as morphine, hydromorphone, or fentanyl) for patients on buprenorphine for pain, and titrating to effect to avoid withdrawal and achieve analgesia 2, 3
- For patients on buprenorphine for opioid use disorder, consider transitioning to methadone maintenance at 30-40 mg/day, as this dose will prevent acute withdrawal in most patients, and methadone binds less tightly to μ-receptors, allowing for more predictable responses to additional analgesics 2, 3
- Coordinate with the patient's addiction treatment program or prescribing physician regarding medication changes, as recommended by the Annals of Internal Medicine 5
Multimodal Pain Management Approach
- Implement adjuvant therapies appropriate to the pain syndrome, including non-pharmacologic treatments, non-opioid analgesics (NSAIDs, acetaminophen), topical agents, and regional anesthetic techniques where applicable, as suggested by the Clinical Infectious Diseases and British Journal of Anaesthesia 6, 7